The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Celtect     3-[3-(4-benzhydrylpiperazin- 1-yl)propyl]...

Synonyms: Cobiona, Oxatimide, Oxatomida, oxatomide, Dasten, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Tinset

 

Psychiatry related information on Tinset

 

High impact information on Tinset

 

Chemical compound and disease context of Tinset

 

Biological context of Tinset

 

Anatomical context of Tinset

 

Associations of Tinset with other chemical compounds

 

Gene context of Tinset

 

Analytical, diagnostic and therapeutic context of Tinset

References

  1. The antiallergic drug oxatomide promotes human eosinophil apoptosis and suppresses IL-5-induced eosinophil survival. Domae, M., Sagara, H., Sakaue, M., Fukuda, T., Kamikawa, Y. J. Allergy Clin. Immunol. (2003) [Pubmed]
  2. Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy. Richards, D.M., Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S. Drugs (1984) [Pubmed]
  3. Effect of oxatomide nasal spray on experimental allergic rhinitis in guinea pigs and rats. Kaise, T., Ohmori, K., Ukai, K., Sakakura, Y. Int. Arch. Allergy Immunol. (1995) [Pubmed]
  4. Newer antihistamines and histamine-release inhibitors. Johnson, P.N. New England and regional allergy proceedings. (1985) [Pubmed]
  5. Drug susceptibility of PCA in WBB6F1-W/Wv mice. Kimura, S., Watanabe, A., Takeuchi, M., Nagata, M., Nakamura, K., Harada, M. Cell. Mol. Life Sci. (1998) [Pubmed]
  6. Urticaria. Recognition, causes and treatment. Ormerod, A.D. Drugs (1994) [Pubmed]
  7. Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. La Rosa, M., Leonardi, S., Marchese, G., Corrias, A., Barberio, G., Oggiano, N., Grimaldi, I. Ann. Allergy Asthma Immunol. (2001) [Pubmed]
  8. Pre-clinical screening of drugs using the mdx mouse. Granchelli, J.A., Pollina, C., Hudecki, M.S. Neuromuscul. Disord. (2000) [Pubmed]
  9. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Haraguchi, K., Ito, K., Kotaki, H., Sawada, Y., Iga, T. Drug Metab. Dispos. (1997) [Pubmed]
  10. Controlled study of oxatomide vs disodium chromoglycate for treating adverse reactions to food. Pacor, M.L., Peroli, P., Favari, F., Lunardi, C. Drugs under experimental and clinical research. (1992) [Pubmed]
  11. A double-blind comparison of oxatomide (R 35 443) and diphenhydramine in the treatment of hay fever. van der Bijl, W.J., Cordier, R., van Dishoeck, E.A., De Proost, W., Vannieuwenhuyse, E. Laryngoscope (1980) [Pubmed]
  12. Acrylamide derivatives as antiallergic agents. 2. Synthesis and structure-activity relationships of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(3-pyridyl)acryl amides. Nishikawa, Y., Shindo, T., Ishii, K., Nakamura, H., Kon, T., Uno, H. J. Med. Chem. (1989) [Pubmed]
  13. Effects of oxatomide and derivatives on high affinity IgE receptor-activated signal transduction pathways in rat basophilic leukemia cells: role of protein tyrosine hyperphosphorylation and inhibition of extracellular calcium influx. Paulussen, J.J., Fischer, M.J., Roozendaal, R.L., van der Heijden, V.C., van Dijken, P., de Mol, N.J., Janssen, L.H. Biochem. Pharmacol. (1998) [Pubmed]
  14. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs. Tohda, Y., Nakajima, S., Shizawa, T., Maeda, K., Ohmori, S., Satoh, H., Ishii, T., Kamitani, T. Clin. Exp. Allergy (1997) [Pubmed]
  15. Laser high performance liquid chromatography determination of prostaglandins in nasal lavage fluid in allergic rhinitis. Sugimoto, M., Sugiyama, S., Yanagita, N., Ozawa, T. Clin. Exp. Allergy (1994) [Pubmed]
  16. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. Patella, V., de Crescenzo, G., Marino, O., Spadaro, G., Genovese, A., Marone, G. Int. Arch. Allergy Immunol. (1996) [Pubmed]
  17. Effect of oxatomide on T-cell activation and the production of interferon-gamma in mite sensitive asthma. Noma, T., Yoshizawa, I., Kawano, Y., Nakajima, T. Eur. J. Pharmacol. (1998) [Pubmed]
  18. Indolo[2,1-c][1,4]benzodiazepines: a new class of antiallergic agents. Ho, C.Y., Hageman, W.E., Persico, F.J. J. Med. Chem. (1986) [Pubmed]
  19. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. Lai, D.S., Lue, K.H., Hsieh, J.C., Lin, K.L., Lee, H.S. Ann. Allergy Asthma Immunol. (2002) [Pubmed]
  20. Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge. Ciprandi, G., Buscaglia, S., Pronzato, C., Benvenuti, C., Cavalli, E., Bruzzone, F., Canonica, G.W. Ann. Allergy Asthma Immunol. (1995) [Pubmed]
  21. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA). Parant, F., Moulsma, M., Gagnieu, M.C., Lardet, G. Therapeutic drug monitoring. (2005) [Pubmed]
  22. Identification of human p450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its inhibitory effect on enzyme activity. Goto, A., Adachi, Y., Inaba, A., Nakajima, H., Kobayashi, H., Sakai, K. Biol. Pharm. Bull. (2004) [Pubmed]
  23. Inhibition of different dosages of oxatomide or placebo on skin prick test and nasal allergen provocation. Piacentini, G.L., Peroni, D.G., Sette, L., Bonizzato, C., Benedetti, M., Boner, A.L. J. Allergy Clin. Immunol. (1991) [Pubmed]
  24. High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma. Kikuchi, K., Ohishi, T., Masuike, T., Ohmori, K., Sakai, K. Arzneimittel-Forschung. (2002) [Pubmed]
  25. Pharmacokinetics of oxatomide given percutaneously to healthy volunteers. Benvenuti, C., Broggini, M., Botta, V., Valenti, M., Broccali, G., Dal Bo, L. Biopharmaceutics & drug disposition. (1992) [Pubmed]
  26. Oxatomide effects in follicular conjunctivitis of presumed allergic cause. A double-blind evaluation. Blockeel, J., Leuridan, O. Ophthalmologica (1980) [Pubmed]
 
WikiGenes - Universities